¡¡
¡¡
¡¡
HOME > ÇÐȸ°£Ç๰ > ¿ë¾î»çÀü
Á¦¸ñ Applicability of Anti-PGL-1 Antibody(IgM) Detection Test on Leprosy Control Programm
ÀúÀÚ Yong Ma Hah, Hae Young Choi, Ki Hye Kim ¼Ò¼Ó Institute for Leprosy research, KLCA
³âµµ 1993 ±Ç 26
È£ 1 ¹øÈ£
½ÃÀÛÆäÀÌÁö 8 ³¡ÆäÀÌÁö 16
÷ºÎ
¿ä¾à Anti-PGL-1 antibody(IgM) detection was remained for monitoring treatment of
multibacillary leprosy. Author has studied this test to apply onto leprosy control
program and following results were obtained.
1. Ninty-two percent of positivity is revealed at multibacillary untreated new leprosy
cases(Table 2).
2. Antibody titers of PGL-1 declined simultanously with the decline of BI(Table 3).
3. Antibody titers of PGL-1 declined simultanously with the BI at the patients
absconded for a longtime (average 35.4mo.) after regular MDT treatment for more than
4 years(Table 4).
4. Antibody titers declining at all case of RFT group patient(Table 5).
5. Among 784 patients in 25 resettlement villages, 31.4% of patients of L-type
revealed positive antibody titer(Table 7).
6. Compliance to MDT became more clarified.
7. Medical control program to resettlement villages to be reconsidered
³»¿ë
 
¡¡
¡¡
¡¡